This may occur through RosA’s capacity to suppress IL-8 production (Luo et al. 2020) and alleviate anxiety by modulating the hypothalamic-pituitary-adrenal axis and upregulating glucocorticoid receptor expression in the hippocampus (Makhathini et al. 2018). Here, CXCL8 is linked to Anxiety.